Chinese Journal of Stroke ›› 2026, Vol. 21 ›› Issue (8): 970-978.DOI: 10.3969/j.issn.1673-5765.2026.08.008

Previous Articles     Next Articles

Short-Term Safety Analysis of Urgent Endovascular Treatment in High-Risk Patients with Acute Symptomatic Severe Anterior Circulation Intracranial Atherosclerotic Stenosis

PENG Zhuli, XIONG Zini, TIAN Dan, LIU Haolin, CHEN Xiaolong, ZHOU Xibu, BAI Xiaoxin   

  1. The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China 
  • Received:2025-12-02 Revised:2026-05-14 Accepted:2026-05-18 Online:2026-08-20 Published:2026-08-20
  • Contact: BAI Xiaoxin, E-mail: bxxzjj@163.com

急性期症状性前循环颅内动脉粥样硬化性重度狭窄高危患者行紧急血管内治疗的短期安全性分析

彭株丽,熊紫妮,田丹,刘浩林,陈小龙,周夕卜,白小欣   

  1. 广州 510006 广州中医药大学第二临床医学院
  • 通讯作者: 白小欣 bxxzjj@163.com

Abstract: Objective To investigate the short-term safety of urgent endovascular treatment (EVT) on the basis of aggressive medical treatment (AMT) in strictly selected high-risk patients with acute symptomatic severe anterior circulation intracranial atherosclerotic stenosis. 
Methods This was a single-center, retrospective cohort study that consecutively enrolled patients with acute symptomatic (TIA or non‑disabling ischemic stroke) severe anterior circulation intracranial atherosclerotic stenosis. Individualized treatment strategies were determined according to clinical manifestations, imaging features, and hemodynamic assessments. High-risk patients—those with neurological fluctuation or deterioration within 72 hours of onset and with severe culprit-vessel stenosis accompanied by downstream hypoperfusion or inadequate collateral compensation—underwent urgent DSA on the basis of AMT, with EVT performed when indicated. According to the treatment modalities and the timing of EVT, patients were divided into three groups: the AMT group (AMT alone), the urgent EVT group (urgent EVT on top of AMT), and the elective EVT group (elective EVT on top of AMT). For subsequent comparisons, to evaluate the stratified treatment strategy of AMT‑based therapy with urgent EVT reserved for high‑risk patients, the AMT group and the urgent EVT group were combined into the stratified strategy group, while the urgent EVT group and the elective EVT group were combined into the EVT group. The primary endpoints were any stroke (ischemic stroke or symptomatic intracranial hemorrhage) or death within 30 days, and disability or death caused by stroke within 30 days. Comparisons were performed against published data from the stenting vs. aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial. 
Results A total of 160 patients were enrolled in this study, including 72 patients with TIA and 133 patients with non‑disabling ischemic stroke; 110 patients (68.8%) were male, with a mean age of (60.8±11.6) years. Thirty-one patients underwent urgent DSA within 72 hours after enrollment. There were 15 patients in the urgent EVT group, 39 in the elective EVT group, and 106 in the AMT group. Any stroke or death within 30 days occurred in 2.8% (3/106) of the AMT group, 3.3% (4/121) of the stratified strategy group, and 1.9% (1/54) of the EVT group; disability or death caused by stroke occurred in 1.9% (2/106), 2.5% (3/121), and 1.9% (1/54), respectively. No numerically higher rates of primary endpoint events were observed compared with the SAMMPRIS medical management group (5.7%; 1.8%) or stenting group (14.7%; 7.1%). Post-hoc sensitivity analysis excluding perforator-territory infarctions yielded consistent findings. 
Conclusions In strictly selected high-risk patients with acute symptomatic severe anterior circulation intracranial atherosclerotic stenosis, urgent EVT superimposed on AMT demonstrated acceptable preliminary short-term safety. As this was an exploratory study, confirmation through multicenter, adequately powered, prospective controlled trials is warranted.

Key words: Symptomatic severe intracranial atherosclerotic stenosis; Endovascular treatment; Acute phase; Treatment strategy

摘要: 目的  探讨经严格筛选的急性期症状性前循环颅内动脉粥样硬化性重度狭窄高危患者,在强化内科治疗(aggressive medical treatment,AMT)基础上实施紧急血管内治疗(endovascular treatment,EVT)的短期安全性。
方法  本研究为单中心、回顾性队列研究,连续纳入急性期症状性(TIA或非致残性缺血性卒中)前循环颅内动脉粥样硬化性重度狭窄患者,根据临床表现、影像学特征及血流动力学评估制订个体化治疗策略。对于发病72 h内存在神经功能波动或进展、责任血管重度狭窄伴低灌注或侧支代偿不良的高危患者,在AMT基础上行紧急DSA,必要时行EVT。根据治疗方式及EVT实施时机,将患者分为AMT组(仅接受AMT)、紧急EVT组(在AMT基础上接受紧急EVT)及择期EVT组(在AMT基础上接受择期EVT);后续进行比较时,为评估以AMT为基础、仅对高危患者行紧急EVT的分层治疗策略,本研究将AMT组与紧急EVT组合并为分层策略组,将紧急EVT组与择期EVT组合并为EVT组。主要结局事件为入组后30 d随访期内发生的任何卒中(包括缺血性卒中和症状性脑出血)或死亡,以及入组后30 d随访期内卒中引起的残疾或死亡,并与支架置入术对比强化药物治疗预防颅内动脉狭窄卒中复发(stenting vs. aggressive medical management for preventing recurrent stroke in intracranial stenosis,SAMMPRIS)试验公开数据进行比较。
结果  本研究共纳入160例患者,其中TIA为72例,非致残性缺血性卒中为133例;男性110例(68.8%),平均年龄(60.8±11.6)岁。入组后72 h内行紧急DSA者31例,紧急EVT组15例,择期EVT组39例,AMT组106例。AMT组入组后30 d随访期内发生的任何卒中或死亡率为2.8%(3/106),入组后30 d随访期内卒中引起的残疾或死亡率为1.9%(2/106);分层策略组分别为3.3%(4/121)和2.5%(3/121);EVT组分别为1.9%(1/54)和1.9%(1/54)。与SAMMPRIS试验药物管理组(5.7%和1.8%)及支架置入组(14.7%和7.1%)相比,各组主要结局事件发生率未见明显增高。事后敏感性分析排除穿支动脉梗死事件后,上述趋势仍然存在。
结论  对于经严格筛选的急性期症状性前循环颅内动脉粥样硬化性重度狭窄高危患者,AMT基础上的紧急EVT初步显示出可接受的短期安全性。本研究为探索性研究,结果需多中心、大样本、前瞻性对照研究进一步验证。

关键词: 症状性颅内动脉重度狭窄; 血管内治疗; 急性期; 治疗策略

CLC Number: